15
Participants
Start Date
December 16, 2019
Primary Completion Date
October 1, 2022
Study Completion Date
October 1, 2022
Aripiprazole Lauroxil
12 month longitudinal aripiprazole lauroxil treatment and assessment follow-through
ARI-ORAL
oral aripiprazole
AL-NCD
Aripiprazole Lauroxil 675 MG/2.4 ML Intramuscular Suspension, Extended Release
University of California, Los Angeles, Los Angeles
Collaborators (1)
Alkermes, Inc.
INDUSTRY
University of California, Los Angeles
OTHER